is toujeo a glp 1 for the Treatment of Type and Type 2 Diabetes Toujeo: Package Insert / Prescribing

FDA (2024)

If you are interested in learning more about medical weight management strategies, including Qsymia, Cape Fear Physical Medicine and Rehab is here to help

Gastrointestinal effectsnausea, vomiting, diarrhea, constipationoccur in 20-60% of users depending on dose escalation speed

The drugs were linked to small reduction 12% in the risk of dementia and other neurocognitive disorders, including Alzheimers disease

These modifications extend the half-life of the hormone to 2.4 h [18]

4 Challenges and future directions 4.1 Safety considerations The safety profile of dual or triple receptor agonists targeting GLP-1, GIP, and GCG receptors in the treatment of MASLD and related metabolic disorders warrants careful evaluation